Senate Democrats are poised to pass a reconciliation bill next week that would, among other things, allow the federal government to "negotiate" prescription drug prices and more.
Sally C. Pipes, president and CEO of the Pacific Research Institute, spoke on the bill's impact and how it will affect inflation and the future of drug development. Sally has recently published op-eds on how the reconciliation package will undermine drug research in the likes of the Washington Examiner, Newsmax, and the Pittsburgh Post-Gazette. Find her article here.
If Ever There Were an Ironclad Scientific Consensus, This Was It. And they were wrong. "The population bomb, doomsday scam, the narrative we’ve been...
HR 3 Rush To Reason November 9 2020 by John Rush
HR 2 Rush To Reason March 2 2021 by John Rush